Maximising the cost-effectiveness of human papillomavirus testing for cervical screening in the context of routine HPV vaccination in Hong Kong: abridged secondary publication

被引:0
|
作者
Leung, S. M. K. [1 ]
Wu, J. [1 ]
Chan, K. K. L. [2 ]
Jit, M. [3 ]
机构
[1] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Peoples R China
[2] Univ Hong Kong, Li Ka Shing Fac Med, Dept Obstet & Gynaecol, Hong Kong, Peoples R China
[3] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:11 / 15
页数:5
相关论文
共 50 条
  • [41] EFFECT OF VACCINATION AGE ON COST-EFFECTIVENESS OF HUMAN PAPILLOMAVIRUS VACCINATION AGAINST CERVICAL CANCER IN CHINA
    Liu, Y. J.
    Zhang, Q.
    Hu, S. Y.
    Zhao, F. H.
    VALUE IN HEALTH, 2014, 17 (07) : A724 - A724
  • [42] Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China
    Yi-Jun Liu
    Qian Zhang
    Shang-Ying Hu
    Fang-Hui Zhao
    BMC Cancer, 16
  • [43] Cost-effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia
    Coupe, V. M. H.
    Berkhof, J.
    Verheijen, R. H. M.
    Meijer, C. J. L. M.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2007, 114 (04) : 416 - 424
  • [44] Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden
    Fogelberg, Sara
    Clements, Mark S.
    Pedersen, Kine
    Sy, Stephen
    Sparen, Par
    Kim, Jane J.
    Burger, Emily A.
    PLOS ONE, 2020, 15 (09):
  • [45] Cost-effectiveness of conventional cytology and HPV DNA testing for cervical cancer screening in Colombia
    Andres-Gamboa, Oscar
    Chicaiza, Liliana
    Garcia-Molina, Mario
    Diaz, Jorge
    Gonzalez, Mauricio
    Murillo, Raul
    Ballesteros, Monica
    Sanchez, Ricardo
    SALUD PUBLICA DE MEXICO, 2008, 50 (04): : 276 - 285
  • [46] Clinical impact and cost-effectiveness of primary cytology versus human papillomavirus testing for cervical cancer screening in England
    Bains, Irenjeet
    Choi, Yoon Hong
    Soldan, Kate
    Jit, Mark
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (04) : 669 - 675
  • [47] Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more
    Goldie, SJ
    Kim, JJ
    Wright, TC
    OBSTETRICS AND GYNECOLOGY, 2004, 103 (04): : 619 - 631
  • [48] Cost-effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in Québec, Canada
    Arthi Vijayaraghavan
    Molly B. Efrusy
    Marie-Hélène Mayrand
    Christopher C. Santas
    Patricia Goggin
    Canadian Journal of Public Health, 2010, 101 : 220 - 225
  • [49] Applying a gender lens on human papillomavirus infection: cervical cancer screening, HPV DNA testing, and HPV vaccination
    Ivan Branković
    Petra Verdonk
    Ineke Klinge
    International Journal for Equity in Health, 12
  • [50] Applying a gender lens on human papillomavirus infection: cervical cancer screening, HPV DNA testing, and HPV vaccination
    Brankovic, Ivan
    Verdonk, Petra
    Klinge, Ineke
    INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH, 2013, 12